(UEF0) UBS Barclays US Liquid - Ratings and Ratios
Corporate, Bonds, US, Hedged, ETF
Description: UEF0 UBS Barclays US Liquid
The UBS Barclays US Liquid Corporates UCITS hedged to EUR A-acc ETF is designed to mirror the performance of the Bloomberg Barclays US Liquid Corporates Index, providing investors with exposure to a diversified portfolio of US corporate bonds while mitigating the impact of currency fluctuations between the US dollar and the euro through a currency hedging strategy.
The fund achieves this by tracking the total return of the underlying index and employing a hedging methodology that involves selling currency forwards at the one-month forward rate to minimize currency risk. This makes it an attractive option for European investors seeking to invest in US corporate bonds without being exposed to exchange rate volatility.
With an Assets Under Management (AUM) of 358.95M EUR, the fund has a considerable presence in the market, indicating a certain level of investor confidence and liquidity. The ETF is listed on XETRA, a major European exchange, ensuring ease of access for investors.
Analyzing the technical data, the ETFs last price is 17.02, slightly above its 20-day Simple Moving Average (SMA) of 16.97, indicating a short-term bullish trend. The 50-day and 200-day SMAs are both at 17.08, suggesting a longer-term neutral to slightly bearish outlook as the current price is slightly below these averages. The Average True Range (ATR) is 0.11, or 0.62%, indicating relatively low volatility.
Given the current technical and fundamental data, a forecast for the ETF could involve a slight consolidation or a minor pull-back towards the 20-day SMA, given its current position relative to the longer-term SMAs. However, the overall trend of US corporate bonds, as reflected by the Bloomberg Barclays US Liquid Corporates Index, is likely to be influenced by broader economic factors such as interest rates and credit spreads.
If interest rates stabilize or decrease and credit spreads narrow, indicating a more favorable environment for corporate bonds, the ETF could see an uptick. Conversely, widening credit spreads or rising interest rates could negatively impact the funds performance. Based on the current technical indicators and assuming a stable macroeconomic environment, a potential target price could be near the 52-week high of 17.57, representing a 2.6% increase from the current price. However, this forecast is contingent on the ETFs ability to maintain its hedging strategys effectiveness and the overall performance of the underlying index.
Additional Sources for UEF0 ETF
UEF0 ETF Overview
Market Cap in USD | 424m |
Category | Other Bond |
TER | 0.20% |
IPO / Inception | 2014-05-30 |
UEF0 ETF Ratings
Growth Rating | -26.8 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | 5.46 |
Analysts | - |
Fair Price Momentum | 15.90 EUR |
Fair Price DCF | - |
UEF0 Dividends
Currently no dividends paidUEF0 Growth Ratios
Growth Correlation 3m | 70.2% |
Growth Correlation 12m | 1.2% |
Growth Correlation 5y | -57.3% |
CAGR 5y | -2.78% |
CAGR/Max DD 5y | -0.10 |
Sharpe Ratio 12m | 0.09 |
Alpha | -0.36 |
Beta | -0.015 |
Volatility | 6.23% |
Current Volume | 0.1k |
Average Volume 20d | 0.6k |
As of July 04, 2025, the stock is trading at EUR 17.39 with a total of 92 shares traded.
Over the past week, the price has changed by +0.44%, over one month by +1.62%, over three months by +0.71% and over the past year by +4.18%.
Probably not. Based on ValueRay´s Analyses, UBS Barclays US Liquid (XETRA:UEF0) is currently (July 2025) not a good stock to buy. It has a ValueRay Growth Rating of -26.84 and therefor a somwhat technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of UEF0 is around 15.90 EUR . This means that UEF0 is currently overvalued and has a potential downside of -8.57%.
UBS Barclays US Liquid has no consensus analysts rating.
According to our own proprietary Forecast Model, UEF0 UBS Barclays US Liquid will be worth about 17.2 in July 2026. The stock is currently trading at 17.39. This means that the stock has a potential downside of -1.27%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 17.2 | -1.3% |